Richa Poddar - 06 Dec 2021 Form 3 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Chief Commercial Officer
Signature
/s/ William Cook, as Attorney in Fact for Richa Poddar
Issuer symbol
AGIO
Transactions as of
06 Dec 2021
Net transactions value
$0
Form type
3
Filing time
15 Dec 2021, 15:56:45 UTC
Next filing
14 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AGIO Common stock 150 06 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AGIO Restricted stock units 06 Dec 2021 Common stock 658 Direct F1, F2
holding AGIO Restricted stock units 06 Dec 2021 Common stock 3,476 Direct F2, F3
holding AGIO Restricted stock units 06 Dec 2021 Common stock 5,000 Direct F2, F4
holding AGIO Restricted stock units 06 Dec 2021 Common stock 6,204 Direct F2, F5
holding AGIO Stock options (right to buy) 06 Dec 2021 Common stock 5,100 $59.68 Direct F6
holding AGIO Stock options (right to buy) 06 Dec 2021 Common stock 3,650 $50.40 Direct F7
holding AGIO Stock options (right to buy) 06 Dec 2021 Common stock 6,860 $77.70 Direct F8
holding AGIO Stock options (right to buy) 06 Dec 2021 Common stock 7,900 $58.86 Direct F9
holding AGIO Stock options (right to buy) 06 Dec 2021 Common stock 2,607 $51.51 Direct F10
holding AGIO Stock options (right to buy) 06 Dec 2021 Common stock 3,102 $56.68 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.
F2 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F3 The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.
F4 The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022.
F5 The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.
F6 This option was granted on June 6, 2016. The shares underlying this option are fully vested.
F7 This option was granted on February 21, 2017. The shares underlying this option are fully vested.
F8 This option was granted on February 16, 2018. The shares underlying this option vest as to 25% of the underlying shares on February 16, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F9 This option was granted on February 22, 2019. The shares underlying this option vest as to 25% of the underlying shares on February 22, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F10 This option was granted on February 14, 2020. The shares underlying this option vest as to 25% of the underlying shares on February 14, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F11 This option was granted on February 10, 2021. The shares underlying this option vest as to 25% of the underlying shares on February 10, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.